What is it about?
This study evaluates the efficacy and safety of two commonly used medicines for osteoarthritis (celecoxib and naproxen) in an Asian population.
Featured Image
Why is it important?
We know that some medicines don't work as well or may have unique safety issues in ethnic populations versus Caucasians. This study evaluates efficacy and safety in an Asian population
Perspectives
Celecoxib is a commonly used medicine for treatment of arthritis. Extensive clinical data is available for effectiveness and safety in Caucasian populations. We now have studied celecoxib in African-American, Asian, and Latino populations adding to the knowledge base regarding safety and efficacy for those physicians wishing to treat those patients in those three ethnic groups
Dr Michael Anthony O'Connell
Pfizer Medical
Read the Original
This page is a summary of: Efficacy and safety of nonsteroidal anti-inflammatory drugs in Asian patients with knee osteoarthritis: summary of a randomized, placebo-controlled study, International Journal of Rheumatic Diseases, May 2015, Wiley,
DOI: 10.1111/1756-185x.12667.
You can read the full text:
Contributors
The following have contributed to this page
